|
|
||||||||
CASE REPORTS |
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, and the Division of Critical Care, Department of Surgery, University of North Carolina School of Medicine, Chapel Hill, North Carolina
Address reprint requests to: Garrett Lam, Division of Maternal-Fetal Medicine, 214 MacNider Building, CB7516, Chapel Hill, North Carolina 27599; E-mail: garrett_lam{at}med.unc.edu.
BACKGROUND: Primary pulmonary hypertension is a rare and dangerous entity in pregnancy. Previous studies have found a 3550% maternal mortality rate in the peripartum period. To date, most reports have described treatment of these patients with diuretics, digoxin, and calcium-channel blockers.
CASE: We describe the successful treatment of a primigravida with severe primary pulmonary hypertension. We used elective intubation before labor, inhaled nitric oxide therapy, and assisted vaginal delivery with epidural anesthesia that resulted in a viable infant and survival of the mother.
CONCLUSION: Nitric oxide can be used to successfully treat primary pulmonary hypertension in pregnancy.
This article has been cited by other articles:
![]() |
P. Ray, G. J. Murphy, and L. E. Shutt Recognition and management of maternal cardiac disease in pregnancy Br. J. Anaesth., September 1, 2004; 93(3): 428 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Badesch, S. H. Abman, G. S. Ahearn, R. J. Barst, D. C. McCrory, G. Simonneau, and V. V. McLaughlin Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest, July 1, 2004; 126(1_suppl): 35S - 62S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Napoli and J. Loscalzo Nitric Oxide and Other Novel Therapies for Pulmonary Hypertension Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1): 1 - 8. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |